# Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation

Study · id `cardio:ct-nct01841242` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01841242](<https://clinicaltrials.gov/study/NCT01841242>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01841242

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2272 participants.

## Technical summary

Registry record NCT01841242. Randomized; no masking; primary purpose prevention. Start 2013-04-23 (actual); primary completion 2021-01-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 2272 participants (enrolled count; ClinicalTrials.gov record NCT01841242, source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)
- Started: 2013-04-23 (actual) (ClinicalTrials.gov record NCT01841242, source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)
- Primary completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT01841242, source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)
- Completion: 2021-01-31 (actual) (ClinicalTrials.gov record NCT01841242, source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT01841242, source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01841242-2025-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
- Acronym: CHLOVIS
- Condition: Heart Failure
- Condition: Arrhythmia
- Intervention (Drug): alcoholic povidone iodine
- Intervention (Drug): alcoholic chlorhexidine
- Lead sponsor: Centre Hospitalier Universitaire de Saint Etienne
- Lead sponsor class: OTHER
- Collaborator: Ministry of Health, France
- Collaborator class: OTHER\_GOV
- Collaborator: C. R. Bard
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Centre Hospitalier Universitaire de Saint Etienne (`cardio:org-centre-hospitalier-universitaire-de-saint-etienne`)
- Registry lists this organization as a collaborator: Ministry of Health, France (`cardio:org-ministry-of-health-france`)
- Registry lists this organization as a collaborator: C. R. Bard (`cardio:org-c-r-bard`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study (`cardio:pubmed-41562534`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 237ffff0aa5e77788654843f554cbc4e977dfc7ec083ac236d3c57a964079232
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
